These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 22012885)

  • 1. Work productivity in scleroderma: analysis from the University of California, Los Angeles scleroderma quality of life study.
    Singh MK; Clements PJ; Furst DE; Maranian P; Khanna D
    Arthritis Care Res (Hoboken); 2012 Feb; 64(2):176-83. PubMed ID: 22012885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Work productivity in systemic sclerosis, its economic burden and association with health-related quality of life.
    Morrisroe K; Sudararajan V; Stevens W; Sahhar J; Zochling J; Roddy J; Proudman S; Nikpour M
    Rheumatology (Oxford); 2018 Jan; 57(1):73-83. PubMed ID: 29155994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unmet Workplace Support Needs and Lost Productivity of Workers With Systemic Sclerosis: A Path Analysis Study.
    Jetha A; Johnson SR; Gignac MAM
    Arthritis Care Res (Hoboken); 2021 Mar; 73(3):423-431. PubMed ID: 31841266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and correlates of sleep disturbance in systemic sclerosis--results from the UCLA scleroderma quality of life study.
    Frech T; Hays RD; Maranian P; Clements PJ; Furst DE; Khanna D
    Rheumatology (Oxford); 2011 Jul; 50(7):1280-7. PubMed ID: 21324979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminant validity, responsiveness and reliability of the rheumatoid arthritis-specific Work Productivity Survey (WPS-RA).
    Osterhaus JT; Purcaru O; Richard L
    Arthritis Res Ther; 2009; 11(3):R73. PubMed ID: 19457255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosis.
    Clements PJ; Wong WK; Hurwitz EL; Furst DE; Mayes M; White B; Wigley F; Weisman M; Barr W; Moreland L; Medsger TA; Steen V; Martin R; Collier D; Weinstein A; Lally E; Varga J; Weiner S; Andrews B; Abeles M; Seibold J
    Arthritis Rheum; 1999 Nov; 42(11):2372-80. PubMed ID: 10555033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.
    Merkel PA; Herlyn K; Martin RW; Anderson JJ; Mayes MD; Bell P; Korn JH; Simms RW; Csuka ME; Medsger TA; Rothfield NF; Ellman MH; Collier DH; Weinstein A; Furst DE; Jiménez SA; White B; Seibold JR; Wigley FM;
    Arthritis Rheum; 2002 Sep; 46(9):2410-20. PubMed ID: 12355489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin Hand Function Scale, Health Assessment Questionnaire (HAQ), Systemic Sclerosis HAQ, and Medical Outcomes Study 36-Item Short Form Health Survey.
    Rannou F; Poiraudeau S; Berezné A; Baubet T; Le-Guern V; Cabane J; Guillevin L; Revel M; Fermanian J; Mouthon L
    Arthritis Rheum; 2007 Feb; 57(1):94-102. PubMed ID: 17266096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validity of the Workers Productivity and Activity Impairment Questionnaire: Specific Health Problem (WPAI:SHP) in patients with systemic sclerosis.
    Morrisroe K; Stevens W; Huq M; Sahhar J; Ngian GS; Zochling J; Roddy J; Proudman SM; Nikpour M;
    Clin Exp Rheumatol; 2017; 35 Suppl 106(4):130-137. PubMed ID: 28516877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the validation status of quality of life and functional disability measures in pulmonary arterial hypertension related to systemic sclerosis: results of a systematic literature analysis by the Expert Panel on Outcomes Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS).
    Kowal-Bielecka O; Avouac J; Pittrow D; Huscher D; Behrens F; Denton CP; Foeldvari I; Humbert M; Matucci-Cerinic M; Nash P; Opitz CF; Rubin LJ; Seibold JR; Strand V; Furst DE; Distler O;
    J Rheumatol; 2011 Nov; 38(11):2419-27. PubMed ID: 21965635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The minimally important difference in clinical practice for patient-centered outcomes including health assessment questionnaire, fatigue, pain, sleep, global visual analog scale, and SF-36 in scleroderma.
    Sekhon S; Pope J; ; Baron M
    J Rheumatol; 2010 Mar; 37(3):591-8. PubMed ID: 20080913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial.
    Clements PJ; Wong WK; Hurwitz EL; Furst DE; Mayes M; White B; Wigley F; Weisman M; Barr W; Moreland L; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner SR; Andrews B; Abeles M; Seibold JR
    Arthritis Rheum; 2001 Mar; 44(3):653-61. PubMed ID: 11263780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of the Health Assessment Questionnaire for Japanese patients with systemic sclerosis--measuring functional impairment in systemic sclerosis versus other connective tissue diseases.
    Morita Y; Muro Y; Sugiura K; Tomita Y; Tamakoshi K
    Clin Exp Rheumatol; 2007; 25(3):367-72. PubMed ID: 17631731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of correlation of the health assessment questionnaire disability index with lung parameters in systemic sclerosis associated pulmonary arterial hypertension.
    Chow S; Pope JE; Mehta S
    Clin Exp Rheumatol; 2008; 26(6):1012-7. PubMed ID: 19210864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of health-related quality of life and fatigue in systemic sclerosis: evaluation of the EuroQol-5D and FACIT-F assessment tools.
    Strickland G; Pauling J; Cavill C; McHugh N
    Clin Rheumatol; 2012 Aug; 31(8):1215-22. PubMed ID: 22588647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of systemic sclerosis on occupational and professional activity with attention to patients with digital ulcers.
    Bérezné A; Seror R; Morell-Dubois S; de Menthon M; Fois E; Dzeing-Ella A; Nguyen C; Hachulla E; Guillevin L; Poiraudeau S; Mouthon L
    Arthritis Care Res (Hoboken); 2011 Feb; 63(2):277-85. PubMed ID: 20824802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life and functional status in systemic sclerosis compared to other rheumatic diseases.
    Johnson SR; Glaman DD; Schentag CT; Lee P
    J Rheumatol; 2006 Jun; 33(6):1117-22. PubMed ID: 16622903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial.
    Khanna D; Furst DE; Clements PJ; Park GS; Hays RD; Yoon J; Korn JH; Merkel PA; Rothfield N; Wigley FM; Moreland LW; Silver R; Steen VD; Weisman M; Mayes MD; Collier DH; Medsger TA; Seibold JR; ;
    J Rheumatol; 2005 May; 32(5):832-40. PubMed ID: 15868618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health values of patients with systemic sclerosis.
    Khanna D; Ahmed M; Furst DE; Ginsburg SS; Park GS; Hornung R; Tsevat J
    Arthritis Rheum; 2007 Feb; 57(1):86-93. PubMed ID: 17266070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using a self-reported functional score to assess disease progression in systemic sclerosis.
    Serednicka K; Smyth AE; Black CM; Denton CP
    Rheumatology (Oxford); 2007 Jul; 46(7):1107-10. PubMed ID: 17426141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.